期刊文献+

男性慢性肝病患者勃起功能障碍研究进展 被引量:1

Erectile dysfunction in male patients with chronic liver diseases
下载PDF
导出
摘要 目的肝脏是性激素、脂质等多种物质代谢的重要器官。男性慢性肝病患者常合并性激素代谢紊乱、糖脂代谢紊乱和精神心理疾病等,容易发生勃起功能障碍,对患者的身心健康和家庭生活造成影响。现有研究表明,男性慢性肝病患者勃起功能障碍患病率在24.6%~85.0%之间,慢性肝炎患者勃起功能障碍患病率为8.6%~78.0%,而肝硬化患者勃起功能障碍患病率为41.2%~92.0%。本文对男性慢性肝病患者发生勃起功能障碍的发病状况、影响因素、可能的发病机制和治疗研究进展进行综述,期望引起广泛的关注,改善患者的身心健康。 Objective Liver is an important organ for the metabolism of sex hormones,lipids and other substances.Male patients with chronic liver disease often suffer from a variety of dysfunctions,such as sex hormone metabolism,glucose and lipid metabolism and mental and psychological disorder.Erectile dysfunction is easy to occur,which affects the physical and mental health and the family life of patients.Existing studies have shown that the prevalence of male erectile dysfunction in patients with chronic liver disease was 24.6%to 85%,the prevalence in chronic hepatitis patients was 8.6%to 78%,and in patients with cirrhosis was 41.2%to 92%.In this paper,we reviewed the incidence,impacting factors,possible pathogenesis,and treatment of erectile dysfunctions in male patients with chronic liver disease.
作者 邓江(综述) 石娟娟 党双锁(审校) Deng Jiang;Shi Juanjuan;Dang Shuangsuo(Department of Infectious Diseases,Second Affiliated Hospital,Xi'an Jiaotong University,Xi'an 710004,China)
出处 《实用肝脏病杂志》 CAS 2021年第6期934-937,共4页 Journal of Practical Hepatology
基金 陕西省重点研发计划项目(编号:2020SF-297) 中央高校基本科研业务费专项资金资助(编号:xjh012019063)。
关键词 肝硬化 慢性肝炎 勃起功能障碍 磷酸二酯酶抑制剂5 Cirrhosis Chronic hepatitis Erectile dysfunctions Phosphodiesterase inhibitor 5
  • 相关文献

参考文献5

二级参考文献46

  • 1郭应禄,胡礼泉.男科学.北京:人民卫生出版社,2005,691-692.
  • 2[1]EASL International Consensus Conference on Hepatitis C.Paris,26-28,February 1999,Consensus Statement.European Association for the Study of the Liver.J Hepatol1999; 30:956-961
  • 3[2]Englert Y,Lesage B,Van Vooren JP,Liesnard C,Place I,Vannin AS,Emiliani S,Delbaere A.Medically assisted reproduction in the presence of chronic viral diseases.Hum Reprod Update 2004; 10:149-162
  • 4[3]Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman ZD,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001; 358:958-965
  • 5[4]Zignego AL,Brechot C.Extrahepatic manifestations of HCV infection:facts and controversies.J Hepatol1999; 31:369-376
  • 6[5]Cacoub P,Poynard T,Ghillani P,Charlotte F,Olivi M,Piette JC,Opolon P.Extrahepatic manifestations of chronic hepatitis C.MULTIVIRC Group.Multidepartment Virus C.Arthritis Rheum 1999; 42:2204-2212
  • 7[6]Pileri P,Uematsu Y,Campagnoli S,Galli G,Falugi F,Petracca R,Weiner AJ,Houghton M,Rosa D,Grandi G,Abrignani S.Binding of hepatitis C virus to CD81.Science 1998; 282:938-941
  • 8[7]Durazzo M,Philipp T,Van Pelt FN,Luttig B,Borghesio E,Michel G,Schmidt E,Loges S,Rizzetto M,Marms MP.Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.Gastroenterology 1995; 108:455-462
  • 9[8]Misiani R,Bellavita P,Fenili D,Borelli G,Marchesi D,Massazza M,Vendramin G,Comotti B,Tanzi E,Scudeller G.Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.Ann Intern Med 1992; 117:573-577
  • 10[9]Ferri C,Monti M,La Civita L,Longombardo G,Greco F,Pasero G,Gentilini P,Bombardieri S,Zignego AL.Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.Blood 1993; 82:3701-3704

共引文献37

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部